Patent Valuation: How Much Is Your Patent Actually Worth?

Patents have no public trading market. No exchange posts bid-ask spreads on them. Two patents covering very similar technology can have wildly different values depending on their remaining term, the breadth of their claims, the size of the market they cover, and whether anyone is actually infringing them.

Valuing a patent — or a patent portfolio — requires combining legal analysis, technical assessment, and financial modeling. Here's how it's done.

Why valuation is hard

The value of a patent is entirely contingent on enforcement. A patent that no one practices and no one infringes is worth the cost of the maintenance fees, minus the administrative hassle. A patent covering a ubiquitous technology practiced by every player in a billion-dollar industry is worth a portion of that industry's profits for the remaining patent term.

Several factors compound the difficulty:

• Validity risk: Any granted patent can be invalidated. A patent subject to a credible IPR petition may be worth a fraction of an identical patent with no validity challenges pending.
• Claim interpretation uncertainty: Courts often interpret patent claim scope differently than the parties expected. Broad claims may be narrowed; narrow claims may be construed more broadly.
• Infringement analysis uncertainty: Whether a given product actually practices the claims — under the all elements rule, under the doctrine of equivalents — often requires litigation to finally resolve.
• No liquid market: Patent transactions are private and terms rarely disclosed. The comparable transactions database is thin and inconsistent.

Approach 1: Cost approach

The cost approach values the patent at what it cost to create and protect the intellectual property — R&D expenditures, prosecution costs, and the cost of recreating the invention from scratch.

Replacement cost method: What would it cost a company to independently develop the same invention and prosecute the same patent claims today?

Historic cost method: What was actually spent on R&D and prosecution?

The cost approach is a floor value — what you have invested. It tells you nothing about what the market would pay, which may be much more (if the invention is commercially important) or much less (if the invention is commercially irrelevant regardless of its quality). Cost approach is most useful for accounting purposes and for setting a minimum acceptable value in negotiations.

Approach 2: Market approach (comparable transactions)

The market approach looks at arm's-length transactions involving similar patents and uses those transactions to estimate value.

Data sources include Royalty Source, ktMINE, IAM Market, and court records (which sometimes include royalty rates admitted or determined in litigation). The challenge is identifying truly comparable patents — same technology area, similar claim breadth, similar remaining term, similar market applicability.

This approach is most reliable when robust transaction data exists: standards-essential patents (SEPs) in wireless communications, pharmaceutical compound patents, widely licensed software patents. It's unreliable for novel technology areas with few comparable transactions.

Approach 3: Income approach (net present value of royalty stream)

The income approach is the most conceptually rigorous. It calculates the present value of the future income the patent is expected to generate.

The steps:

1. Define the royalty base: What revenue would the patent generate if licensed to all infringing parties in all relevant markets? This requires estimating the size of the infringing market and the number of units sold.

2. Set the royalty rate: What percentage of revenue would a reasonable licensee pay for rights to this technology? Industry benchmarks, comparable transactions, and expert analysis contribute to this estimate.

3. Project the royalty stream: Multiply the royalty base by the royalty rate over the patent's remaining enforceable term, accounting for market growth or contraction.

4. Discount to present value: Use an appropriate discount rate reflecting the risk of the royalty stream — the uncertainty of infringement, validity, and market projections. Higher-risk patents warrant higher discount rates (often 15–35%).

For example: a patent with 8 years remaining, covering a product sold to a market generating $500 million in annual revenue, with a 3% royalty rate and 20% discount rate, generates a gross royalty projection of $120 million (8 years × $15M/year) discounted to approximately $60–70 million present value.

Approach 4: Relief-from-royalty method

A variant of the income approach used most commonly in tax and accounting contexts. The patent is valued at what the patent holder would have had to pay in royalties to a third party if they didn't own the patent — i.e., the relief from royalty payments that patent ownership provides.

This approach is common in transfer pricing and intercompany IP transactions because it's auditable and consistent with how tax authorities evaluate IP value.

Factors that increase patent value

• Broad independent claims: Claims with few elements and wide language cover more potential infringers. More infringers means more royalty potential.
• Large addressable market: A patent covering a niche component in a niche market is worth less than a patent covering a fundamental function in a mass-market product.
• Active enforcement history: A patent that has survived validity challenges — through IPR, in litigation, or in examination — is more valuable than one that hasn't been tested.
• Continuation portfolio: A patent backed by pending continuation applications that can pursue additional claims adds future optionality. The parent patent's expiration doesn't end the story.
• Long remaining term: Eight years of remaining protection is worth more than two.
• Documented infringement: A patent with a clear, documented infringement case against a solvent, identifiable defendant is worth more than one where infringement is uncertain.

Factors that decrease patent value

• Narrow claims: Claims that require many specific elements — each of which can be designed around — limit the universe of infringers.
• Approaching expiration: Maintenance fees plus declining royalty term push value down. A patent expiring in 18 months has limited licensing leverage.
• Alice vulnerability: Software and business method patents with abstract claims are subject to challenge under Alice Corp. v. CLS Bank. Claims that haven't been tested against Alice analysis carry a significant validity discount.
• Crowded prior art: Art that narrowly missed anticipating the claims creates ongoing invalidity risk.
• Narrow market application: Patents in stagnant or declining markets generate declining royalty streams.

The rule of 25%

A rough heuristic widely used in patent licensing: the licensor receives approximately 25% of the licensee's operating profits attributable to the patented technology. The licensee keeps 75%, reflecting the effort and investment of commercializing the invention.

This is a starting point for negotiation, not a rule of law. It has been criticized by courts (the Federal Circuit rejected the "25% rule of thumb" as a default in Uniloc USA v. Microsoft in 2011) and should be grounded in industry-specific data and case-specific facts rather than applied mechanically.

Real-world reference points

NTP v. RIM: NTP's wireless email patents settled for $612.5 million. The PTAB subsequently rejected most of NTP's claims on reexamination — suggesting the market valued enforcement leverage more than legal validity.

PageRank patent: Stanford licensed US6285999 to Google in exchange for equity worth approximately $336 million when Google went public. The patent itself wasn't cash-generating — it was the entrance ticket to a business that became worth hundreds of billions.

Qualcomm SEPs: Qualcomm's FRAND-committed standards-essential patents generate billions in annual royalties. Their value comes from universal adoption of the standards they cover — every LTE device in the world must practice certain Qualcomm patents. This is an extreme case: SEP portfolios are valued differently from non-SEP portfolios precisely because FRAND commitments cap royalty rates.

The lesson: patent value is determined more by what business context surrounds the patent than by any intrinsic quality of the patent itself.

PatentBrief is not a law firm. Nothing here is legal advice. Patent valuation for significant transactions requires a qualified IP valuation expert and legal counsel.